“IMULAN BioTherapeutics is dedicated to finding solutions to complex veterinary diseases by developing a new generation of therapies. Our company consists of veterinarians, scientists, and pet owners with a commitment to see innovative and approved products reach the market. This commitment is resulting in the development of brand new solutions for diseases such as viral infections, atopic dermatitis, asthma, and sepsis. We hope that our products will bring hope for pet owners and enable veterinarians to offer these advancements to their patients. IMULAN is proud to distribute Lymphocyte T-Cell Immunomodulator, an example of our commitment to providing innovative products for diseases where no other approved treatment exists.”
About the CEO:
Dr. Craig Woods has spent his career in veterinary research and in private practice.
Dr. Woods started his career in veterinary practice from 1995 until 1999. In 1999, he entered industry holding various senior management positions in research and business development. In 2004, Dr. Woods founded IMULAN BioTherapeutics, LLC to advance a new generation of biologics which propose to solve some of the most frustrating diseases in veterinary medicine. Dr. Woods is a licensed veterinarian and continues to practice veterinary medicine in Arizona.
Dr. Woods obtained his B.S. (Biology), M.S. (Biochemistry), and Doctor of Veterinary Medicine (D.V.M.) from the University of Missouri and his M.B.A. from Arizona State University. He has conducted research in immunology, genetics, toxicology and biochemistry and has a special interest in immune modulation and leukocyte biology. Dr. Woods frequently gives lectures about new advances in veterinary medicine to scientists, veterinarians and the general public.
